NDC 54473-184

CounterAct Night

Acetaminophen, Diphenydramine Hci, Phenylephrine Hci

CounterAct Night is a Oral Tablet, Coated in the Human Otc Drug category. It is labeled and distributed by Melaleuca, Inc.. The primary component is Acetaminophen; Diphenhydramine Hydrochloride; Phenylephrine Hydrochloride.

• Product ID: 54473-184_65e96c30-97cd-7b1f-e053-2991aa0aa9ea
• NDC: 54473-184
• Product Type: Human Otc Drug
• Proprietary Name: CounterAct Night
• Generic Name: Acetaminophen, Diphenydramine Hci, Phenylephrine Hci
• Dosage Form: Tablet, Coated
• Route of Administration: ORAL
• Marketing Start Date: 2011-08-01
• Marketing Category: OTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL
• Application Number: part341
• Labeler Name: Melaleuca, Inc.
• Substance Name: ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE
• Active Ingredient Strength: 325 mg/1; mg/1; mg/1
• NDC Exclude Flag: N
• Listing Certified Through: 2019-12-31

Packaging

NDC 54473-184-36

1 BLISTER PACK in 1 BOX (54473-184-36) > 36 TABLET, COATED in 1 BLISTER PACK (54473-184-01)

• Marketing Start Date: 2018-01-01
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 54473-184-01 [54473018401]

CounterAct Night TABLET, COATED

• Marketing Category: OTC monograph final
• Application Number: part341
• Product Type: HUMAN OTC DRUG
• Marketing Start Date: 2018-02-23
• Marketing End Date: 2019-12-31

NDC 54473-184-36 [54473018436]

CounterAct Night TABLET, COATED

• Marketing Category: OTC monograph final
• Application Number: part341
• Product Type: HUMAN OTC DRUG
• Marketing Start Date: 2018-01-01
• Marketing End Date: 2019-12-31

Drug Details

Active Ingredients

Ingredient	Strength
ACETAMINOPHEN	325 mg/1

OpenFDA Data

• SPL SET ID: c500f07b-1a07-4afb-a98c-4a8ee9e16675
• Manufacturer:
  • Melaleuca, Inc.
• UNII:
  • TC2D6JAD40
  • 362O9ITL9D
  • 04JA59TNSJ
• RxNorm Concept Unique ID - RxCUI:
  • 1046751